RVT-1401, A Novel Anti-FcRn Monoclonal Antibody, Is Well Tolerated in Healthy Subjects and Reduces Plasma IgG Following Subcutaneous or Intravenous Administration (P5.2-079)
用户wxb8loTerxGI
1个月前
92
10
已关闭
DOI: 10.1212/wnl.92.15_supplement.p5.2-079
文献链接: https://www.neurology.org/doi/10.1212/WNL.92.15_supplement.P5.2-079
其他信息:
出版社: Ovid Technologies (Wolters Kluwer Health)
作者: Jon Collins; Lori Jones; Michele Snyder; Eric Sicard; Paul Griffin; Lindsey Webster; Regan Fong; Christine Coquery; Stephen Piscitelli
